|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2002-12-18
|
|
pubmed:abstractText |
To assess the significance of the method of percutaneous radiofrequency ablation (PRFA) combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0529-5815
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
826-9
|
|
pubmed:dateRevised |
2010-3-10
|
|
pubmed:meshHeading |
pubmed-meshheading:12487855-Adult,
pubmed-meshheading:12487855-Aged,
pubmed-meshheading:12487855-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12487855-Carcinoma, Hepatocellular,
pubmed-meshheading:12487855-Chemoembolization, Therapeutic,
pubmed-meshheading:12487855-Combined Modality Therapy,
pubmed-meshheading:12487855-Female,
pubmed-meshheading:12487855-Humans,
pubmed-meshheading:12487855-Liver Neoplasms,
pubmed-meshheading:12487855-Male,
pubmed-meshheading:12487855-Middle Aged,
pubmed-meshheading:12487855-Neoplasm Recurrence, Local,
pubmed-meshheading:12487855-Survival Rate
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
[Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
|
|
pubmed:affiliation |
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|
